Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT
Author(s): David Austin Added: 1 year ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicity.PROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced… View more

CV Disease in Special Populations
Survey on Interdisciplinary Management of Cardiotoxicity in Outpatient Sett
Author(s): Silvio Quick , Lorena Payo-Anez , Clara Marx Casimiro de Almeida , et al Added: 1 year ago

Guidelines & Statements

Imaging & Diagnostics
Aarti Asnani
Job title: MD
Dr Asnani is Associate Director and an attending physician in the Cardio-Oncology Program at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts and is an active researcher in the field. She joined BIDMC in 2017 and prior to this worked at the Massachusetts General Hospital. She earned her medical degree at the Duke School of Medicine, Durham, North Carolina in 2008, one of the… View more
Research Area(s) / Expertise:
Research Area(s) / Expertise:
Alicia Okines
Research Area(s) / Expertise:

Cardio-oncology

 Job title: Consultant Medical Oncologist, Royal Marsden Hospital, London, UK
Dr Alicia Okines is a consultant in medical oncology at the Royal Marsden NHS Foundation Trust and the team leader for the Breast Cancer Systemic Therapy Trials team.Dr Okines studied pharmacology at the University of Sheffield, where she also pursued her medical training. Throughout her oncology residency at The Royal Marsden Hospital and the Institute of Cancer Research, she earned an MD(Res),… View more
Frailty in Cardio-oncology
Author(s): Ilaria Torre , Lorenzo Tinti , Ludovica Amore , et al Added: 3 weeks ago

CV Disease in Special Populations

Heart Failure
Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches
Author(s): Giulia Tamburrini , Celia de Cobos García , Teresa López Fernández Added: 6 months ago

CV Disease in Special Populations

Heart Failure
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

 Job title: Assistant Professor
Dr Giselle Melendez is anAssistant Professor atWake Forest University School of Medicine, Winston-Salem, US.Commencing her scientific career at the University of South Carolina School of Medicine, Dr. Melendez focused on molecular mediators of myocardial extracellular matrix remodeling and heart failure. Notably, her research uncovered vital insights into inflammatory cytokines TNF-α, IL-6, and… View more
Dr Michael D Stubblefield is Medical Director for Cancer Rehabilitation at Kessler Institute for Rehabilitation, National Medical Director for Select Medical’s ReVital Cancer Rehabilitation Program and National Medical Director for Complex Medical Rehabilitation for Select Medical’s Inpatient Rehabilitation Hospital Division. He is President of the International Cancer Rehabilitation Foundation… View more